Increased CD112 expression in methylcholanthrene- Induced tumors in CD155-deficient mice

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Nagumo, Yoko ^a   Iguchi Manaka, Akiko ^a   Yamashita Kanemaru, Yumi ^a   Abe, Fumie ^a   Bernhardt, Gü Nter ^b   Shibuya, Akira ^a   Shibuya, Kazuko ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD155 ANTIGEN; CELL ANTIGEN; NECTIN 2; UNCLASSIFIED DRUG; 3 METHYLCHOLANTHRENE; CD226 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2 RECEPTOR BETA; NECTINS; T CELL IG AND ITIM DOMAIN PROTEIN, MOUSE; T LYMPHOCYTE ANTIGEN; TAA1 PROTEIN, MOUSE; TUMOR ANTIGEN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FIBROSARCOMA; FLOW CYTOMETRY; IMMUNOSURVEILLANCE; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN DEFICIENCY; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL; TUMOR GROWTH; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMICALLY INDUCED; GENETICS; HUMAN; METABOLISM; PATHOLOGY; T LYMPHOCYTE;

MUS;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CYTOKINES; FIBROSARCOMA; HUMANS; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; KILLER CELLS, NATURAL; MALE; METHYLCHOLANTHRENE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM PROTEINS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 84911459501     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112415     Document Type: Article

References (33)

1. Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22: 329-360.
2. Swann JB, Smyth MJ (2007) Immune surveillance of tumors. J Clin Invest 117: 1137-1146.
3. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23: 225-274.
4. Dunn GP, Koebel CM, Schreiber RD (2006) Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6: 836-848.
5. Springer TA (1990) Adhesion receptors of the immune system. Nature 346: 425-434.
6. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, et al. (1996) DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4: 573-581.
7. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, et al. (2003) Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198: 557-567.
8. Tahara-Hanaoka S, Shibuya K, Onoda Y, Zhang H, Yamazaki S, et al. (2004) Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int Immunol 16: 533-538.
9. Tahara-Hanaoka S, Miyamoto A, Hara A, Honda S, Shibuya K, et al. (2005) Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands. Biochem Biophys Res Commun 329: 996-1000.
10. Lopez M, Aoubala M, Jordier F, Isnardon D, Gomez S, et al. (1998) The human poliovirus receptor related 2 protein is a new hematopoietic/endothelial homophilic adhesion molecule. Blood 92: 4602-4611.
11. Iwasaki A, Welker R, Mueller S, Linehan M, Nomoto A, et al. (2002) Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: Implications for poliovirus infection. J Infect Dis 186: 585-592.
12. Masson D, Jarry A, Baury B, Blanchardie P, Laboisse C, et al. (2001) Overexpression of the CD155 gene in human colorectal carcinoma. Gut 49: 236-240.
13. Tahara-Hanaoka S, Shibuya K, Kai H, Miyamoto A, Morikawa Y, et al. (2006) Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood 107: 1491-1496.
14. Carlsten M, Bjorkstrom NK, Norell H, Bryceson Y, van Hall T, et al. (2007) DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res 67: 1317-1325.
15. Castriconi R, Dondero A, Corrias MV, Lanino E, Pende D, et al. (2004) Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: Critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Cancer Res 64: 9180-9184.
16. Pende D, Spaggiari GM, Marcenaro S, Martini S, Rivera P, et al. (2005) Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the poliovirus receptor (CD155) and nectin-2 (CD112). Blood 105: 2066-2073.
17. El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, et al. (2007) The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res 67: 8444-8449.
18. Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, et al. (2009) The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 10: 48-57.
19. Stanietsky N, Simic H, Arapovic J, Toporik A, Levy O, et al. (2009) The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci U.S.A. 106: 17858-17863.
20. Wang PL, O'Farrell S, Clayberger C, Krensky AM (1992) Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily. J Immunol 148: 2600-2608.
21. Chan CJ, Martinet L, Gilfillan S, Souza-Fonseca-Guimaraes F, Chow MT, et al. (2014) The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat Immunol 15: 431-438.
22. Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M (2004) Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J Immunol 172: 3994-3998.
23. Iguchi-Manaka A, Kai H, Yamashita Y, Shibata K, Tahara-Hanaoka S, et al. (2008) Accelerated tumor growth in mice deficient in DNAM-1 receptor. J Exp Med 205: 2959-2964.
24. Maier MK, Seth S, Czeloth N, Qiu Q, Ravens I, et al. (2007) The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens. Eur J Immunol 37: 2214-2225.
25. Seth S, Qiu Q, Danisch S, Maier MK, Braun A, et al. (2011) Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells. J Biol Chem 286: 39153-39163.
26. Liu J, Qian X, Chen Z, Xu X, Gao F, et al. (2012) Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226. J Immunol 188: 5511-5520.
27. Lui WY, Sze KL, Lee WM (2006) Nectin-2 expression in testicular cells is controlled via the functional cooperation between transcription factors of the Sp1, CREB, and AP-1 families. J Cell Physiol 207: 144-157.
28. Sakamoto KM, Frank DA (2009) CREB in the pathophysiology of cancer: Implications for targeting transcription factors for cancer therapy. Clin Cancer Res 15: 2583-2587.
29. Angel P, Hattori K, Smeal T, Karin M (1988) The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55: 875-885.
30. Ostrand-Rosenberg S, Sinha P (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182: 4499-4506.
31. Nabekura T, Shibuya K, Shibuya A (2011) Reply to Seth, et al.: DNAX accessory molecule-1 (DNAM-1) plays an important role in alloreactive CD8 + T cells responsible for the exacerbation of acute graft-versus-host disease. Proc Natl Acad Sci U.S.A 108: E34.
32. Nabekura T, Shibuya K, Takenaka E, Kai H, Shibata K, et al. (2010) Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in mice. Proc Natl Acad Sci U.S.A. 107: 18593-18598.
33. Seth S, Ravens I, Lee CW, Glage S, Bleich A, et al. (2011) Absence of CD155 aggravates acute graft-versus-host disease. Proc Natl Acad Sci U.S.A. 108: E32-E33.